Vigilant Biosciences Announces the Launch of the OncAlert Labs OraMark™ Test to Aid U.S. Clinicians in the Early Detection of Oral Cancer May 31, 2016

Vigilant Biosciences, Inc. Names Scientific Advisory Board and Expands Leadership Team, Appoints Dr. Michael Donovan as Chief Clinical Officer May 25, 2016 FORT LAUDERDALE, Florida

Vigilant Biosciences’ Scientific Founder and Chief Scientific Officer, Elizabeth Franzmann, M.D., is Honored by Greater Miami Chamber of Commerce with 2016 Health Care Heroes® Award

Vigilant Biosciences Receives CE Mark for OncAlert® Oral Cancer RAPID Test to Aid in Diagnosis of Oral Cancer May 4, 2016 FORT LAUDERDALE, Florida Vigilant

National Oral Cancer Awareness Survey Reveals 83 Percent of Adults Want to be Screened for Oral Cancer During Routine Check-ups; Only 37 Percent Actually Are

Vigilant Biosciences Announces Publication of Research on Risk Stratification System for Oral Cancer Screening March 31, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a